tirzepatide slows gastric emptying Ozempic & Stomach Problems 10 Reasons Tirzepatide is the

Neuroprotection in PD is limited by its clinical and biological heterogeneity, suboptimal preclinical models, lack of established disease progression biomarkers, complex pathophysiology, the existence of effective symptomatic therapies which hamper the detection of actual disease modification, and trial design

Research has demonstrated that DSIP modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing basal corticotropin (ACTH) levels and blocking stress-induced ACTH release

Concurrent use of hormone therapy and tirzepatide was also associated with improved cardiometabolic outcomes, suggesting that hormone therapy might enhance the therapeutic effects of tirzepatide in this population

10.1056/NEJMra1703100 18

And the stomach and liver are anterior structures